Document Detail

Managing patients after myocardial infarction.
MedLine Citation:
PMID:  1968904     Owner:  NLM     Status:  MEDLINE    
Thrombolytic therapy clearly saves lives when administered in the first critical hours after acute MI. Consequently, most patients can now be treated initially at the community hospital level. Transfer to a tertiary center may be reserved for those who become symptomatic after thrombolysis, which, of course, is not a panacea. Reducing the risks of reinfarction and death remain major issues.
L S Cohen
Related Documents :
8544674 - Comparison of "accelerated" tissue plasminogen activator with streptokinase for treatme...
10983734 - A review of the long term effects of thrombolytic agents.
9651794 - The "door-to-needle blitz" in acute myocardial infarction: the impact of a cqi project.
12635684 - Intraocular hemorrhage after systemic thrombolytic therapy in a patient with exudative ...
19632524 - Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acut...
10451234 - Characteristics of intracardiac potentials at successful ablation sites in concealed wo...
Publication Detail:
Type:  Clinical Trial; Journal Article; Review    
Journal Detail:
Title:  Hospital practice (Office ed.)     Volume:  25     ISSN:  8750-2836     ISO Abbreviation:  Hosp. Pract. (Off. Ed.)     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-04-13     Completed Date:  1990-04-13     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8404149     Medline TA:  Hosp Pract (Off Ed)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  49-60     Citation Subset:  AIM; IM    
Yale University.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use
Angioplasty, Transluminal, Percutaneous Coronary
Aspirin / therapeutic use
Calcium Channel Blockers / therapeutic use
Clinical Trials as Topic
Heart Function Tests
Myocardial Infarction / rehabilitation,  therapy*
Streptokinase / administration & dosage,  therapeutic use
Thrombolytic Therapy*
Tissue Plasminogen Activator / therapeutic use
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Calcium Channel Blockers; 50-78-2/Aspirin; EC 3.4.-/Streptokinase; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of ...
Next Document:  Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferati...